visit 3 showed a decreasing trend but were not significant (2.51 ± 1.38 vs. 2.37 ± 1.14, P = 0.577) ( Fig. 5 ).
← all excerpts
Evaluation of the efficacy and safety of conversion from the tacrolimus capsule to tablet in stable liver transplant recipients with maintenance therapy: a 24-week, open-label, single-center, phase IV exploratory clinical study.
2
—
—
The sentences
visit 3 showed an increasing trend but were not significant (3.80 ± 0.95 vs. 4.12 ± 0.81, P = 0.068).